1. Canadian Study of Health and Aging Working Group: Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ. 1994, 150: 899-913.
2. Østbye T, Crosse E: Net economic costs of dementia in Canada. CMAJ. 1994, 151: 1457-1464.
3. Hux MJ, O'Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S: Relation between severity of Alzheimer's disease and costs of caring. CMAJ. 1998, 159: 457-465.
4. Pryse-Phillips W, Sternberg S, Rochon P, Naglie G, Strong H, Feightner J: The use of medications for cognitive enhancement. Can J Neurol Sci. 2001, 28 (suppl 1): S108-S114.
5. Huserau D, Wolfson C, Shukla VK: Drug treatments for Alzheimer's disease efficacy, outcome measurements and cost-effectiveness. Ottawa: Canadian Coordinating Office of Health Technology Assessment (CCOHTA). 2001, Technology Overview no.4